|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 157.10 EUR | +1.29% |
|
+1.75% | +32.02% |
| 06-05 | HC Wainwright Starts Ipsen Coverage with Buy Rating | MT |
| 06-02 | Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 159.25 | +2.68% | 16 | ||||||
| 1,215.79 | +6.99% | 29 | ||||||
| 252.87 | +6.03% | 23 | ||||||
| 253.55 | +12.71% | 29 | ||||||
| 360.76 | +11.38% | 17 | ||||||
| 220.95 | +22.5% | 21 | ||||||
| 155.2 | +4.03% | 21 | ||||||
| 352.5 | +4.37% | 30 | ||||||
| 311.78 | +10.13% | 23 | ||||||
| 157.83 | +29.92% | 29 | ||||||
| 29.19 | +14.01% | 27 | ||||||
| 63.08 | +13.45% | 25 | ||||||
| 548.69 | +25.93% | 29 | ||||||
| 96.92 | +27.51% | 23 | ||||||
| 20.77 | +8.07% | 19 | ||||||
| 9,973.33 | +31.92% | 15 | ||||||
| 6,136.87 | +21.04% | 15 | ||||||
| 81.26 | +72.86% | 16 | ||||||
| 49.47 | +39.87% | 19 | ||||||
| 41.27 | +22.91% | 11 | ||||||
| Average | 1,024.07 | +19.42% | 22 | ||||||
| Weighted average by Cap. | 713.57 | +12.64% | 25 |
- Stock Market
- Stocks
- IPN Stock
- Sector Ipsen
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition